| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO
1 company
Saccomano Nicholas A serves as a President and CEO at OKUR. Across recent SEC filings that breaks down to 0 buys and 8 sells. Those positions are worth an estimated $33K at current prices.
Historically, Saccomano Nicholas A's trades have earned a below-average insider score of 31/100 across 6 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -50.7%.
The biggest single holding is OKUR (~$33K) as President and CEO. The recent filings there lean toward selling, a net 1,396 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | OKUR Onkure Therapeutics, Inc. | President and CEO | Sell | 87 | $2.97 | $258.76 | -0.8% | - | - | |
| Jun 22, 2026 | OKUR Onkure Therapeutics, Inc. | President and CEO | Sell | 86 | $4.40 | $378.08 | -0.8% | -31.1% | - | |
| Mar 23, 2026 | OKUR Onkure Therapeutics, Inc. | President and CEO | Sell | 86 | $4.16 | $357.46 | -1.2% | +11.6% | - | |
| Dec 22, 2025 | OKUR Onkure Therapeutics, Inc. | President and CEO | Sell | 87 | $2.97 | $258.19 | -1.2% | +34.5% | - | |
| Sep 22, 2025 | OKUR Onkure Therapeutics, Inc. | President and CEO | Sell | 88 | $2.62 | $230.87 | -2.4% | +13.4% | +18.8% | |
| Jun 23, 2025 | OKUR Onkure Therapeutics, Inc. | President and CEO | Sell | 88 | $2.38 | $209.81 | -2.4% | +8.3% | +74.3% | |
| Apr 7, 2025 | OKUR Onkure Therapeutics, Inc. | President and CEO | Sell | 874 | $2.94 | $2,569.52 | -19.2% | -22.7% | +38.8% |